These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18700552)

  • 1. [Oxidative stress and mild hypertension].
    Saito Y; Nakamura T; Kurabayashi M
    Nihon Rinsho; 2008 Aug; 66(8):1525-9. PubMed ID: 18700552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?
    Touyz RM
    Hypertension; 2004 Sep; 44(3):248-52. PubMed ID: 15262903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of hypertension--reactive oxygen species and antioxidants: a basic science update for the clinician.
    Montezano AC; Touyz RM
    Can J Cardiol; 2012 May; 28(3):288-95. PubMed ID: 22445098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats.
    Chung S; Park CW; Shin SJ; Lim JH; Chung HW; Youn DY; Kim HW; Kim BS; Lee JH; Kim GH; Chang YS
    Nephrol Dial Transplant; 2010 Feb; 25(2):389-99. PubMed ID: 19749146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of an ARB on endothelial progenitor cell function and cardiovascular oxidation in hypertension.
    Yu Y; Fukuda N; Yao EH; Matsumoto T; Kobayashi N; Suzuki R; Tahira Y; Ueno T; Matsumoto K
    Am J Hypertens; 2008 Jan; 21(1):72-7. PubMed ID: 18091747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevension of hypertension by angiotensin receptor blockers in human--TROPHY study].
    Ohya Y; Inoue T
    Nihon Rinsho; 2008 Aug; 66(8):1596-600. PubMed ID: 18700563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities.
    Paravicini TM; Touyz RM
    Diabetes Care; 2008 Feb; 31 Suppl 2():S170-80. PubMed ID: 18227481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of renal medullary oxidative and/or carbonyl stress in salt-sensitive hypertension and diabetes.
    Mori T; Ogawa S; Cowely AW; Ito S
    Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):125-31. PubMed ID: 22150746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies.
    Liu H; Kitazato KT; Uno M; Yagi K; Kanematsu Y; Tamura T; Tada Y; Kinouchi T; Nagahiro S
    J Hypertens; 2008 Jul; 26(7):1435-45. PubMed ID: 18551021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the angiotensin II type 1 receptor antagonist valsartan on the expression of superoxide dismutase in hypertensive patients.
    Yang HY; Kao PF; Chen TH; Tomlinson B; Ko WC; Chan P
    J Clin Pharmacol; 2007 Mar; 47(3):397-403. PubMed ID: 17322151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible role of oxidative stress in the pathogenesis of hypertension.
    Ceriello A
    Diabetes Care; 2008 Feb; 31 Suppl 2():S181-4. PubMed ID: 18227482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress and antioxidant treatment in hypertension and the associated renal damage.
    Manning RD; Tian N; Meng S
    Am J Nephrol; 2005; 25(4):311-7. PubMed ID: 15956781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of cortical COX-2 in salt-sensitive hypertension: role of angiotensin II and reactive oxygen species.
    Jaimes EA; Zhou MS; Pearse DD; Puzis L; Raij L
    Am J Physiol Renal Physiol; 2008 Feb; 294(2):F385-92. PubMed ID: 18094033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress, Noxs, and hypertension: experimental evidence and clinical controversies.
    Montezano AC; Touyz RM
    Ann Med; 2012 Jun; 44 Suppl 1():S2-16. PubMed ID: 22713144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of RAS in prehypertension].
    Inaba S; Iwai M; Horiuchi M
    Nihon Rinsho; 2008 Aug; 66(8):1503-8. PubMed ID: 18700549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between nitric oxide and angiotensin II in the endothelium: role in atherosclerosis and hypertension.
    Schulman IH; Zhou MS; Raij L
    J Hypertens Suppl; 2006 Mar; 24(1):S45-50. PubMed ID: 16601573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is oxidative stress a therapeutic target in cardiovascular disease?
    Münzel T; Gori T; Bruno RM; Taddei S
    Eur Heart J; 2010 Nov; 31(22):2741-8. PubMed ID: 20974801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benidipine, an anti-hypertensive drug, inhibits reactive oxygen species production in polymorphonuclear leukocytes and oxidative stress in salt-loaded stroke-prone spontaneously hypertensive rats.
    Matsubara M; Akizuki O; Ikeda J; Saeki K; Yao K; Sasaki K
    Eur J Pharmacol; 2008 Feb; 580(1-2):201-13. PubMed ID: 18048030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does increased oxidative stress cause hypertension?
    Grossman E
    Diabetes Care; 2008 Feb; 31 Suppl 2():S185-9. PubMed ID: 18227483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
    Leiter LA; Lewanczuk RZ
    Am J Hypertens; 2005 Jan; 18(1):121-8. PubMed ID: 15691626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.